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STUDY
Analysis of Globule Types in Malignant Melanoma
Jin Xu, BS; Kapil Gupta, PhD; William V. Stoecker, MS, MD; Yamini Krishnamurthy; Harold S. Rabinovitz, MD;
Austin Bangert, BS; David Calcara, BS; Margaret Oliviero, ARNP; Joseph M. Malters, MD; Rhett Drugge, MD;
R. Joe Stanley, PhD; Randy H. Moss, PhD; M. Emre Celebi, PhD
Objective: To identify and analyze subtypes of glob-
ules based on size, shape, network connectedness,
pigmentation, and distribution to determine which
globule types and globule distributions are most
frequently associated with a diagnosis of malignant
melanoma.
Design: Retrospective case series of dermoscopy im-
ages with globules.
Setting: Private dermatology practices.
Participants: Patients in dermatology practices.
Intervention: Observation only.
MainOutcomeMeasure: Association of globule types
with malignant melanoma.
Results:The presence of large globules (odds ratio [OR],
5.25) and globules varying in size (4.72) or shape (5.37)
had the highest ORs for malignant melanoma among all
globule types and combinations studied. Classical glob-
ules (dark, discrete, convex, and 0.10-0.20 mm) had a
higher risk (OR, 4.20) than irregularly shaped globules
(dark, discrete, and not generally convex) (2.89). Glob-
ules connected to other structures were not significant
in the diagnosis of malignant melanoma. Of the differ-
ent configurations studied, asymmetric clusters have the
highest risk (OR, 3.02).
Conclusions: The presence of globules of varying size
or shape seems to be more associated with a diagnosis
of malignant melanoma than any other globule type or
distribution in this study. Large globules are of particu-
lar importance in the diagnosis of malignant melanoma.
Arch Dermatol. 2009;145(11):1245-1251
D ERMOSCOPY IS A NONIN-vasive imaging tech-nique that uses opticalmagnification with fluidimmersion or with cross-
polarized lighting to allow better clinical
assessment of skin lesions.1 Dermoscopy
has been shown to improve diagnostic ac-
curacy of pigmented lesions when used by
practitioners with formal training.2,3
Dots and globules were defined to-
gether at a virtual dermoscopy consensus
meeting in 2000 as black, brown, round
to oval, various-sized structures regu-
larly or irregularly distributed within a
melanocytic lesion.1 Dots and globules are
differentiated by size, with several stud-
ies4-7 reporting that globules exceed
0.1 mm in diameter.
Brown and black globules seen in
melanocytic lesions must be distin-
guished from the blue-gray globules seen
in basal cell carcinoma.1 If the globules
are present in a regular distribution, they
are indicative of a benign melanocytic
lesion.1,4-6,8,9 If they are present in an
irregular (also called uneven,5 nonuni-
form,8 or haphazard4) distribution pat-
tern, they are indicative of a malignant
melanoma.1,4-6,8,9 In addition, globules of
uneven size and shape are characteristic
of malignant melanoma.1,4-6,8,9
In most of the diagnostic studies that
measured sensitivity and specificity of dots
and globules, the 2 features were studied
together. The 2000 consensus meeting
about dermoscopy found that the pres-
ence of dots and globules in an irregular
distribution had a sensitivity of 75% and
a specificity of 64% in melanoma diagno-
sis.1 In a study of the 7-point checklist, Ar-
genziano et al9 found a similar 73.7% sen-
sitivity for irregular dots and globules,with
a higher specificity of 82.0%.However, Sa-
lopek et al10 could not confirm the impor-
tance of dots and globules in distinguish-
ing early melanoma from atypical nevi.
The objective of this study was to iden-
tify and analyze subtypes of globules based
on size, shape, network connectedness,
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pigmentation, and distribution to determine which glob-
ule types and globule distributions are most frequently
associated with a diagnosis of malignant melanoma.
METHODS
The image set used in this study consists of 600 digital der-
moscopy images of melanocytic lesions, 325 of which had
globules. This image set included 175 invasive malignant
melanomas, 319 dysplastic nevi with mild or moderate atypia,
and 106 nevocellular nevi without atypia. Only invasive mela-
nomas were included in this study. One hundred twenty-two
of the malignant melanoma images were obtained from a pre-
publication version of the American Academy of Dermatology
DVD on Dermoscopy, edited by Harold S. Rabinovitz et al.
Images of 53 malignant melanomas and the 2 classes of nevi
were acquired at 3 clinics (The Dermatology Center, Rolla,
Missouri; Skin and Cancer Associates, Plantation, Florida; and
Sheard and Drugge, PC, Stamford, Connecticut). The images
had a typical resolution of 1024768 pixels. Images were
acquired via 1 of 2 contact dermoscopy instruments using a
glass plate with a fluid interface (Dermaphot; Heine Optotech-
nik GMBH and Co, Herrsching, Germany; or DermLite Fluid;
3Gen, San Juan Capistrano, California). The Phelps County
Regional Medical Center Institutional Review Board, Rolla,
Missouri, approved this research, and each subject or subject’s
parent or guardian signed a consent form for this research. All
melanomas were biopsied and examined by a dermatopa-
thologist, and all benign lesions were biopsied or followed up
and determined to have no change. The median Breslow
thickness for those melanomas that had this measurement
available was 0.35 mm.
For all 325 images of pigmented lesions with globules from
these image sets, students (J.X., Y.K., A.B., andD.C.) and a der-
matologist (W.V.S.) identified globules and variant globule-
like structures. These globules and variant structures were iden-
tified as 1 of the following 6 types (Figure1): (a) classical (dark
[heavily pigmented], discrete globules with convex shape, 0.10-
0.20 mm), (b) large (dark, discrete globules of varying shape,
0.20-0.70 mm), (c) irregular (dark, discrete globules with ir-
regular nonconvex shape, 0.10-0.20 mm), (d) light (discrete
convex globules with light coloring, 0.05-0.70 mm), (e) small
dot-globule variant (dark, discrete globules, 0.03-0.05mm), or
(f ) connect-globule variant (dark, nondiscrete globules con-
nected to a pigment network or a blotch, 0.05-0.20 mm). The
classical globule sizes were classified as 0.03 to 0.05 mm, 0.05
to 0.10 mm, and 0.10 to 0.20 mm in diameter. Globule size
was measured as the greatest diameter, determined using the
known 10 magnification of the images. We did not attempt
to separate black globules from brown globules, as is some-
times done in the literature, because we found that few glob-
ules have pigmentation so dark as to be considered black and
because such cases appear against a dark background. Glob-
ule size for each optical platform was calibrated using images
that contained ruler scales within the images. Using these im-
ages with ruler scales and the known resolution of the images
in pixels, we determined the upper and lower limits of pixel
diameter for each category of globule size. For example, fully
zoomed images (DermLite Fluid) from the clinics were cali-
brated at 0.01mmper pixel; images that were not fully zoomed
were calibrated by the scale visible on the images. Other im-
ages (Dermaphot) from the atlas were calibrated at 0.0125mm
per pixel. In the past, globule shape has been defined as round
or oval, but globules of pigmented lesions commonly have a
blob shape such as an imperfect egg shape or rounded trap-
ezoid shape, as shown in Figures 2,3,4,5, and6 (the green
globules are considered of regular shape). Therefore, regular
globule shape was assigned only if the globule outline was
rounded and generally convex. Otherwise, globules were clas-
sified as irregular. Elongation was the most common charac-
teristic of irregular globules in our set of lesions. Other glob-
ule types are defined in Figure 1. Figures 2 through 6 show
examples of the different globule types in benign and malig-
nant nevocellular lesions. The presence or absence of each glob-
ule type was recorded in a database.
Three globule distribution characteristics were scored as
present or absent, as summarized in Figure 1. The first glob-
ule distribution type, eccentric, is defined as an overall unbal-
anced globule distribution, shown in Figures 2 and 5. The sec-
ond globule distribution type, asymmetric clusters, is defined
as a group of 3 or more globules in an unbalanced position, as
shown in Figures 2, 4, and 5. The third globule distribution
type, peripheral rim, is defined as an outermost distribution,
with globules at or near the rim of the lesion and distributed
around a significant portion of the lesion, as shown in Figures 4
and 6. Some images may have more than 1 distribution type,










e. Small dot-globule variant†
f. Connect-globule variant†
Eccentric
Discrete, dark, generally convex and
of classical size, 0.10-0.20 mm
Discrete, dark, 0.20-0.70 mm
Discrete, dark, shape not classical,
not convex, has protrusions, 0.10-
0.20 mm, general shape is not ovoid
Lightly pigmented and discrete, any
shape, 0.05-0.70 mm
Discrete, dark, and small (0.03-0.05 mm), 
generally lack discernible shape
Not discrete; adjacent to or within other
dark structures, including pigment
network and structureless areas
(0.05-0.20 mm)
Overall unbalanced globule distribution;
the centroid of the globules is significantly
off center; it is closer to the edge of the
lesion than to the centroid of the lesion
A globule cluster (≥3 globules within
1 mm) is asymmetric if no cluster is
present on the opposite side of the
best axis of symmetry within the lesion
Outermost distribution, with globules at
or near the rim of the lesion and 
distributed around a significant portion
of the lesion rim
Lesion has globules with size differing
by at least a factor of 2
Lesion has ≥1 classical or 1 large globule
(type a or type b) and ≥1 irregular globule
(type c)
Lesion has ≥1 light globule of type d and
≥1 classical, large, or irregular globule of







Figure 1. Definitions of globule and globule distribution types. *Globule
types are illustrated. †Connected globular structures and dot-like globular
structures, although not generally considered globules, are included in this
study to examine their association with melanoma. ‡A minimum of
3 globules is needed for any globule distribution assignment. §Only
nonvariant globules are considered in globule distribution and compound
globule assignments.
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images may have none of the distribution types, as shown in
Figure 3. Figure 4 has 2 small asymmetric clusters, although
the entire distribution is symmetric around the major axis of
the lesion; therefore, the distribution type was scored as asym-
metric clusters. No globule distribution type was assigned un-
less 3 ormore globules were present andmost of the lesion bor-
der was present. Only nonvariant globules were used in
distribution type assessments.
Figure 2. Malignant melanoma with globules of different sizes and shapes. The globule distribution type is eccentric and shows asymmetric clusters but no
peripheral rim. Note that globules marked with green are not necessarily perfectly round or oval but are generally convex. The lesion outline used in determining
distribution type is shown in the inset at center. Green indicates classical; red, irregular; yellow, light; lavender, small dot-globule variant; light blue, large; and
blue, connect-globule variant.
Figure 3. Benign nevocellular nevus with regularly distributed globules. The globule distribution type is not peripheral rim, not eccentric, and is without
asymmetric clusters. Note that these benign globules are not perfectly round or oval.
Figure 4. Benign nevocellular nevus. The globule distribution type is not eccentric but has a peripheral rim and asymmetric clusters. Note that many of these
benign globules are not perfectly round or oval.
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The assessment of global distribution type (eccentric, asym-
metric clusters, or peripheral rim) was made independently by
2 dermatologists (W.V.S. and J.M.M.), who achieved consen-
sus on any differing assessments. These dermatologists used
the following definitions for the distribution types. Eccentric
types have a distribution with the globule centroid (center of
all globules weighted by area) closer to the edge of the lesion
than to the center of the lesion. A cluster is a discrete group of
3 or more globules within 1 mm and is asymmetric if no clus-
ter is present on the opposite side of the best axis of symmetry
for the lesion. The peripheral rim distributionwas assigned only
to those lesions with globules at or near the lesion rim and dis-
tributed around a significant portion of the lesion rim. Tomini-
mize the likelihood that distribution type assessments were af-
fected by knowledge of the diagnosis, distribution types were
determined by overlaying globule images on the lesion out-
lines shown in Figure 2 (inset).
For the globule data gathered, sensitivity, specificity, and
odds ratios (ORs) were calculated using the individual fea-
tures. P values were computed from the 2 distribution using
the Wald 2 value (uncorrected Pearson product moment
correlation). Sensitivity, specificity, positive predictive value,
and ORs were calculated as follows: Sensitivity=true posi-
tive / (true positive false negative). Specificity=true nega-
tive / (false positive true negative). Positive Predictive
Value=true positive / (true positive false positive).11 Odds
Ratios=(true positive true negative) /(false negative false
positive).
RESULTS
Of 175 malignant melanomas, 112 lesions (64.0%) had
globules of any type. Of 425 benign nevi, 213 (50.1%)
had globules of any type. Therefore, the OR for malig-
nant melanoma among globules of any type is 1.77, 1.80
if variant globules are not considered (P .001 for both).
One hundred fifty-four of 319 dysplastic nevi (48.3%)
and 60 of 106 nevocellular nevi (56.6%) had at least 1
type of globule. Every malignant melanoma with glob-
ules had at least 1 nonvariant type of globule, so expand-
ing the definition of globules to include the connect-
globule variant or small dot-globule variant adds nothing
to the sensitivity of globule presence for malignant mela-
noma diagnosis.
Statistics for the various globule and globule distri-
bution types identified in the study are given in Figure7.
The OR estimate for malignant melanoma for any der-
Figure 5. Malignant melanoma. The globule distribution type is eccentric and includes asymmetric clusters, but there is no peripheral rim.
Figure 6. Malignant melanoma. Although the peripheral rim is present in this lesion, other signs of malignant melanoma (blue-gray veil and irregular pigment
network) can be seen in the left upper quadrant. Dark globules of varying size and shape are present at the 12-o’clock position.
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moscopy feature is defined as the ratio of 2 odds ob-
tained from these data (the odds for melanoma with the
feature divided by the odds for melanoma without the
feature). The highest OR for malignant melanoma of any
single globule type, 5.25, was obtained for large, dark,
discrete globules (0.20 mm). The second highest OR,
4.20, was obtained for classical globules (dark, discrete,
convex globules, 0.10-0.20 mm). This OR falls to 2.41
and 2.24 for successively lower limits of globule sizes of
0.05 mm and 0.03 mm, respectively, as shown in
Figure 7.
Of the globule and globule distribution types, glob-
ules varying in size (OR, 4.72) and shape (OR, 5.37) had
the highest ORs for malignant melanoma (Figure 8).
Light globules and the small dot-globule variant hadORs
of less than 2. The connect-globule variant was not found
to be statistically significant. Only 7 lesions (2 malig-
nant melanomas and 5 benign lesions) in our study had
a peripheral rim distribution type, too few lesions for sig-
nificance. Both cases of malignant melanoma with a pe-
ripheral rim distribution type had other important indi-
cators of melanoma, as shown in Figure 6.
When the original lesion images were used, the ORs
for malignant melanoma were 4.80 for the eccentric dis-
tribution type and 2.71 for asymmetric clusters distri-
bution type. Knowledge of the diagnosis probably led to
bias in distribution type assignment for these subjective
measures. When only lesion outlines were used, the OR
decreased to 1.94 for the eccentric distribution type and
increased to 3.02 for asymmetric clusters distribution
type, which suggests bias in distribution type assign-
ments when the original image is used. The 2 observers
disagreed on 9.8% of the eccentric distribution type
assignments and on 12.9% of the asymmetric clusters
distribution type assignments before consensus was
reached using the definitions described in the “Meth-
ods” section.
COMMENT
Even with dermoscopy, the differentiation of early ma-
lignant melanoma from benign pigmented lesions re-
mains a difficult challenge. Of all dermoscopic findings,
dots and globules that are of irregular size, shape, and
distribution have been found to be among the most im-
portant dermoscopic structures to aid in this discrimi-
nation.1,4-9,11,12 Annessi et al8 analyzed dots and globules
separately and found irregular, nonuniform globules
(globules varying in size and shape that had nonuni-
form distribution) to be among the 6 most sensitive and
specific features for the identification of thin mela-
noma. In that study, nonuniformity in distribution alone
had a higher positive predictive value than irregularity
in size or shape alone, although both featureswere needed
to achieve statistical significance. These findings are sum-
marized by the clinical rule that “[m]elanomas have glob-
ules that are uneven in size and shape and most impor-
tant, are also unevenly distributed.”5(p238)
We studied globules of varying size, differing shape,
and uneven (eccentric) distribution type separately. In
our study, all 3 categories achieved significance in mela-
noma discrimination, with size and shape variations
achieving greater melanoma discrimination than un-
even distribution. The uneven distribution patterns are
themost subjective of all of the features studied. The ob-
servers found difficulty in determining eccentric distri-
bution type, especially in borderline cases, because of dif-








































Figure 8. Statistics on various lower limits of globule sizes calculated from






































4.20 (2.87-6.15) <.001 50 81
5.25 (2.95-9.31) <.001 21 95
2.89 (2.01-4.17) <.001 51 74
1.98 (1.38-2.83) <.001 47 69
1.54 (1.80-2.19) .02 51 60
0.85 (0.56-1.72) .49 23 73
1.94 (1.17-3.21) <.001 17 90
3.02 (2.08-4.39) <.001 47 77
0.97 (0.22-4.39) .79 01 99
4.72 (3.23-6.87) <.001 52 81
5.37 (3.54-8.16) <.001 42 88
2.71 (1.87-3.93) <.001 45 77
Figure 7. Statistics for globule and globule distribution types.
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Statistics obtained for 3 lower limits of globule sizes
(Figure 8) show a higher OR for the classical lower limit
of 0.10 mm than for 0.05 mm or 0.03 mm. Some sup-
port for considering globules smaller than 0.10 mm is
found in the study by Scope et al,13 in which aggregates
of bright cells as small as 0.05 mm on confocal micros-
copy were correlated with globules that were barely de-
tectable on dermoscopy. Therefore, a lower limit for glob-
ule size of approximately 0.05 mm could be proposed.
Inclusion of smaller globules adds the benefit of greater
size range. In practice, measurement of globule size is
not feasible. An alternative definition of the lower glob-
ule size limit could be applied, namely, that globules are
large enough to have perceptible shape. This definition
has limitations because perception of globule shape can
vary with the dermoscopy platform used.
Only 55 of 325 images had globules larger than 0.20
mm. The largest globule that we observed was 0.66mm.
In our study, an empiric upper limit cutoff of 0.70 mm
was used to define large globules. We found that 4.5%
of benign lesions had globules between 0.20 and 0.70mm.
In contrast, 20.3% of malignant melanomas had glob-
ules in this size range.
In addition to the retrospective nature of the study,
other limitations are the lack of blinding of diagnosis
among observers, the high ratio of malignant melano-
mas to benign lesions, and the likelihood of errors in glob-
ule determination and marking. The possibilities of er-
rors inmarking the globules and diagnostic biaswere kept
to aminimumby the 3-pass technique of an undergradu-
ate student (Y.K. or A.B.) marking the globules, cor-
rected by a medical student (J.X. or D.C.), and then cor-
rected by a dermatologist (W.V.S.) experienced in
dermoscopy,who adjusted the students’markings for each
lesion. The students were less influenced by diagnosis
in their markings and had less bias in distribution type
assignments. The dermatologist corrected less than 15%
of the individual globule markings or database entries.
The technique of overlaying globule images on the le-
sion outlines was used to delineate the types of globules
and to allow efficient checking of globule classification.
Lesion outlines were used for globule distribution typ-
ing to reduce the possibility of bias in assessment, but
the possibility of bias remained because of lesion out-
line recognition.
The lesions included in the study were obtained from
3 private dermatology practices in the United States and
are believed to be representative of such lesions but may
not be generalizable to lesions seen in academic settings
or in other geographic locations. The percentage of le-
sions from our series that had globules was similar to that
found in university studies in other locations. Steiner et
al14 found 60.7% of nevocellular nevi, 55.0% of dysplas-
tic nevi, and 43.8% of malignant melanomas to have
brown globules compared with our totals of 56.6% of ne-
vocellular nevi, 48.3% of dysplastic nevi, and 64.0% of
malignantmelanomas that had globules and related struc-
tures. Menzies et al15 found 60% and 94% of malignant
melanomas to have black and brown dots or globules,
respectively. The methods of counting globules in these
studies are not strictly comparable. The high ratio of ma-
lignantmelanomas to benign lesions in our study has the
disadvantage of a higher ratio than is seen in other set-
tings but has the advantage of a greater number of mela-
nomas to allow better characterization of globules among
these lesions.
Another caveat is that globules seem to be less com-
mon in earlier melanomas.We have noted fewer globules
in the invasive melanomas observed during the past few
years. This is in agreement with the observation by Salo-
pek et al,10 who did not find that dots or globules are im-
portant indistinguishingearlymelanoma fromatypicalnevi.
Neviwith a global cobblestone or globular patternwere
scored as lacking globules. There was a potential for con-
fusion of globules with this global cobblestone pattern
in nevi. The nevi with a globular pattern usually have
larger globules, and they are more regular and less dis-
crete, as found by Hofmann-Wellenhof et al.16 Using the
requirement that globules should be discrete or con-
nected to other structures, we found no globules on the
6 nevi with the global cobblestone pattern in our lesion
set.
In summary, for this series of lesions with globules,
features that are most predictive of malignant mela-
noma are the following: heavily pigmented (dark), dis-
crete, convex globules; globules exceeding 0.20 mm in
diameter; and the presence of globules of varying size or
shape. The presence of globules varying in shape had the
highest OR for malignant melanoma among all globule
types and combinations studied.Asymmetric clusters seem
to be more frequently associated with malignant mela-
noma than eccentric globules. The connect-globule vari-
ant did not reach statistical significance for diagnosing
malignant melanoma.
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Archives Web Quiz Winner
C ongratulations to the winner of our August quiz,Abhilasha Williams, MBBS, MD, Department of
Dermatology, ChristianMedical College, Vellore, India.
The correct answer to our August challenge was
lichen striatus. For a complete discussion of this case, see
the Off-Center Fold section in the September Archives
(Ramos-Herberth F, BishopK,Kim J. Linear pruritic erup-
tion with onychodystrophy in a 1-year-old girl. Arch
Dermatol. 2009;145[9]:1053-1058).
Be sure to visit the Archives of DermatologyWeb site
(http://www.archdermatol.com) to try your hand at the
interactive quiz. We invite visitors to make a diagnosis
based on selected information from a case report or other
feature scheduled to be published in the followingmonth’s
print edition of the Archives. The first visitor to e-mail
our Web editors with the correct answer will be recog-
nized in the print journal and on our Web site and will
also receive a free copy of The Art of JAMA II.
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